Literature DB >> 24793694

A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer.

Ji-Young Kim1, Taraswi Banerjee1, Aurimas Vinckevicius2, Qianyi Luo3, J Brandon Parker1, Mairead R Baker4, Ishwar Radhakrishnan3, Jian-Jun Wei5, Grant D Barish6, Debabrata Chakravarti7.   

Abstract

Upon androgen stimulation, PKN1-mediated histone H3 threonine 11 phosphorylation (H3T11P) promotes AR target gene activation. However, the underlying mechanism is not completely understood. Here, we show that WDR5, a subunit of the SET1/MLL complex, interacts with H3T11P, and this interaction facilitates the recruitment of the MLL1 complex and subsequent H3K4 tri-methylation (H3K4me3). Using ChIP-seq, we find that androgen stimulation results in a 6-fold increase in the number of H3T11P-marked regions and induces WDR5 colocalization to one third of H3T11P-enriched promoters, thus establishing a genome-wide relationship between H3T11P and recruitment of WDR5. Accordingly, PKN1 knockdown or chemical inhibition severely blocks WDR5 chromatin association and H3K4me3 on AR target genes. Finally, WDR5 is critical in prostate cancer cell proliferation and is hyperexpressed in human prostate cancers. Together, these results identify WDR5 as a critical epigenomic integrator of histone phosphorylation and methylation and as a major driver of androgen-dependent prostate cancer cell proliferation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24793694      PMCID: PMC4075454          DOI: 10.1016/j.molcel.2014.03.043

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  56 in total

1.  An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.

Authors:  Jindan Yu; Jianjun Yu; Ram-Shankar Mani; Qi Cao; Chad J Brenner; Xuhong Cao; Xiaoju Wang; Longtao Wu; James Li; Ming Hu; Yusong Gong; Hong Cheng; Bharathi Laxman; Adaikkalam Vellaichamy; Sunita Shankar; Yong Li; Saravana M Dhanasekaran; Roger Morey; Terrence Barrette; Robert J Lonigro; Scott A Tomlins; Sooryanarayana Varambally; Zhaohui S Qin; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

Review 2.  Signals and combinatorial functions of histone modifications.

Authors:  Tamaki Suganuma; Jerry L Workman
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

Review 3.  Regulation of chromatin by histone modifications.

Authors:  Andrew J Bannister; Tony Kouzarides
Journal:  Cell Res       Date:  2011-02-15       Impact factor: 25.617

Review 4.  Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers.

Authors:  Ping Chi; C David Allis; Gang Greg Wang
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

Review 5.  Roles of histone H3-lysine 4 methyltransferase complexes in NR-mediated gene transcription.

Authors:  Seunghee Lee; Robert G Roeder; Jae W Lee
Journal:  Prog Mol Biol Transl Sci       Date:  2009-10-07       Impact factor: 3.622

6.  Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.

Authors:  Eric Metzger; Axel Imhof; Dharmeshkumar Patel; Philip Kahl; Katrin Hoffmeyer; Nicolaus Friedrichs; Judith M Müller; Holger Greschik; Jutta Kirfel; Sujuan Ji; Natalia Kunowska; Christian Beisenherz-Huss; Thomas Günther; Reinhard Buettner; Roland Schüle
Journal:  Nature       Date:  2010-03-14       Impact factor: 49.962

7.  Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network.

Authors:  Yen-Sin Ang; Su-Yi Tsai; Dung-Fang Lee; Jonathan Monk; Jie Su; Kajan Ratnakumar; Junjun Ding; Yongchao Ge; Henia Darr; Betty Chang; Jianlong Wang; Michael Rendl; Emily Bernstein; Christoph Schaniel; Ihor R Lemischka
Journal:  Cell       Date:  2011-04-07       Impact factor: 41.582

8.  Subunit composition and substrate specificity of a MOF-containing histone acetyltransferase distinct from the male-specific lethal (MSL) complex.

Authors:  Yong Cai; Jingji Jin; Selene K Swanson; Michael D Cole; Seung Hyuk Choi; Laurence Florens; Michael P Washburn; Joan W Conaway; Ronald C Conaway
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

Review 9.  Deconstructing repression: evolving models of co-repressor action.

Authors:  Valentina Perissi; Kristen Jepsen; Christopher K Glass; Michael G Rosenfeld
Journal:  Nat Rev Genet       Date:  2010-02       Impact factor: 53.242

Review 10.  Histone H3 lysine 4 (H3K4) methylation in development and differentiation.

Authors:  Joel C Eissenberg; Ali Shilatifard
Journal:  Dev Biol       Date:  2009-08-21       Impact factor: 3.582

View more
  51 in total

1.  Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth.

Authors:  D Obinata; K Takayama; K Fujiwara; T Suzuki; S Tsutsumi; N Fukuda; H Nagase; T Fujimura; T Urano; Y Homma; H Aburatani; S Takahashi; S Inoue
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

2.  Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy.

Authors:  Varadha Balaji Venkadakrishnan; Adam D DePriest; Sangeeta Kumari; Dhirodatta Senapati; Salma Ben-Salem; Yixue Su; Giridhar Mudduluru; Qiang Hu; Eduardo Cortes; Elena Pop; James L Mohler; Gissou Azabdaftari; Kristopher Attwood; Rajal B Shah; Christina Jamieson; Scott M Dehm; Cristina Magi-Galluzzi; Eric Klein; Nima Sharifi; Song Liu; Hannelore V Heemers
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

3.  lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.

Authors:  Peng Gu; Xu Chen; Ruihui Xie; Jinli Han; Weibin Xie; Bo Wang; Wen Dong; Changhao Chen; Meihua Yang; Junyi Jiang; Ziyue Chen; Jian Huang; Tianxin Lin
Journal:  Mol Ther       Date:  2017-05-06       Impact factor: 11.454

4.  WDR5 Facilitates Human Cytomegalovirus Replication by Promoting Capsid Nuclear Egress.

Authors:  Bo Yang; Xi-Juan Liu; Yongxuan Yao; Xuan Jiang; Xian-Zhang Wang; Hong Yang; Jin-Yan Sun; Yun Miao; Wei Wang; Zhen-Li Huang; Yanyi Wang; Qiyi Tang; Simon Rayner; William J Britt; Michael A McVoy; Min-Hua Luo; Fei Zhao
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

5.  COBLL1 modulates cell morphology and facilitates androgen receptor genomic binding in advanced prostate cancer.

Authors:  Ken-Ichi Takayama; Takashi Suzuki; Tetsuya Fujimura; Satoru Takahashi; Satoshi Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-23       Impact factor: 11.205

6.  Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer.

Authors:  Zhenhua Yang; Kushani Shah; Theodore Busby; Keith Giles; Alireza Khodadadi-Jamayran; Wei Li; Hao Jiang
Journal:  J Clin Invest       Date:  2018-07-23       Impact factor: 14.808

Review 7.  The MYC-WDR5 Nexus and Cancer.

Authors:  Lance R Thomas; Audra M Foshage; April M Weissmiller; William P Tansey
Journal:  Cancer Res       Date:  2015-09-17       Impact factor: 12.701

8.  lncRNA GCAWKR Promotes Gastric Cancer Development by Scaffolding the Chromatin Modification Factors WDR5 and KAT2A.

Authors:  Mingzhe Ma; Yan Zhang; Mingzhe Weng; Ye Hu; Yi Xuan; YiRen Hu; Kun Lv
Journal:  Mol Ther       Date:  2018-09-11       Impact factor: 11.454

9.  GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex.

Authors:  Bin He; Rainer B Lanz; Warren Fiskus; Chuandong Geng; Ping Yi; Sean M Hartig; Kimal Rajapakshe; John Shou; Liping Wei; Shrijal S Shah; Christopher Foley; Sue Anne Chew; Vijay K Eedunuri; Diego J Bedoya; Qin Feng; Takashi Minami; Constantine S Mitsiades; Anna Frolov; Nancy L Weigel; Susan G Hilsenbeck; Daniel G Rosen; Timothy Palzkill; Michael M Ittmann; Yongcheng Song; Cristian Coarfa; Bert W O'Malley; Nicholas Mitsiades
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

10.  TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression.

Authors:  Ken-ichi Takayama; Aya Misawa; Takashi Suzuki; Kiyoshi Takagi; Yoshihide Hayashizaki; Tetsuya Fujimura; Yukio Homma; Satoru Takahashi; Tomohiko Urano; Satoshi Inoue
Journal:  Nat Commun       Date:  2015-09-25       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.